The Evolving Role of Chemotherapy in the Management of Pleural Malignancies: Current Evidence and Future Directions

August 19, 2025 | Comments Off on The Evolving Role of Chemotherapy in the Management of Pleural Malignancies: Current Evidence and Future Directions

Cancers 2025 June 25 [Link] Yuliya Semenova, Zhandos Burkitbayev, Nurtas Kalibekov, Alexandr Digay, Bakhyt Zhaxybayev, Oxana Shatkovskaya, Saule Khamzina, Dinara Zharlyganova, Zhuldyz Kuanysh, Almira Manatova Abstract Pleural malignancies represent a…

Medical Thoracoscopy in Malignant Pleural Effusion

August 18, 2025 | Comments Off on Medical Thoracoscopy in Malignant Pleural Effusion

Cureus 2025 June 10 [Link] Amit K Rath, Sudarsan Pothal, Pallavi Bharadwaj Abstract Introduction: Malignant pleural effusion (MPE) is a common complication of advanced malignancies, often resulting in significant morbidity…

Prognostic Value of the HALP Score in Metastatic Mesothelioma: A Retrospective Study

August 15, 2025 | Comments Off on Prognostic Value of the HALP Score in Metastatic Mesothelioma: A Retrospective Study

Oncology 2025 July 8 [Link] Ozlem Dogan, Yakup Duzkopru, Tulay Eren Abstract Background: Malignant mesothelioma is a rare but aggressive cancer with limited treatment options and poor prognosis. Hemoglobin, Albumin,…

A giant peritoneal mesothelioma extending to the pelvic floor: A case report and review of the literature

August 14, 2025 | Comments Off on A giant peritoneal mesothelioma extending to the pelvic floor: A case report and review of the literature

Journal of Cancer Research and Therapeutics 2025 April 1 [Link] Mathew Thomas, Harikrishnan Nandakumar, Parth Sampat, Stephen Graziano Abstract Malignant peritoneal mesothelioma (MPM) is a rare malignancy originating from the…

Prolonged Survival in Mesothelioma Patients Without Surgical Resection: A National Cancer Database Analysis

August 13, 2025 | Comments Off on Prolonged Survival in Mesothelioma Patients Without Surgical Resection: A National Cancer Database Analysis

The Annals of Thoracic Surgery 2025 June 28 [Link] Peter L Zhan, Maureen E Canavan, Justin M Bader, Daniel J Boffa, Benjamin J Resio, Gavitt A Woodard Abstract Background: The…

Long term side effects after volumetric modulated arc therapy to the pleura in patients with malignant pleural mesothelioma

August 12, 2025 | Comments Off on Long term side effects after volumetric modulated arc therapy to the pleura in patients with malignant pleural mesothelioma

Lung Cancer 2025 August [Link] Vishruta Dumane, Juliana Runnels, Raja Flores, Andrea Wolf, Weijia Fu, Madhu Mazumdar, Thomas Marron, Jorge Gomez, Kenneth Rosenzweig Abstract Purpose: Lung-sparing pleurectomy/decortication (P/D) is the…

Clinical and Pathologic Phenotyping of mesotheliomas developing in carriers of Germline BAP1 Mutations

August 11, 2025 | Comments Off on Clinical and Pathologic Phenotyping of mesotheliomas developing in carriers of Germline BAP1 Mutations

Journal of Thoracic Oncology 2025 June 27 [Link] Michele Carbone, Michael Minaai, Muaiad Kittaneh, Thomas Krausz, Markku M Miettinen, Qiang Pan Hammarström, Lennart Hammarström, Hassan Abolhassani, Ian Pagano, Ronghui Xu,…

Immune Composition and Immunotherapy Outcomes of Mesothelioma with BAP1, CDKN2A, MTAP, and NF2 Alterations

August 8, 2025 | Comments Off on Immune Composition and Immunotherapy Outcomes of Mesothelioma with BAP1, CDKN2A, MTAP, and NF2 Alterations

Journal of Thoracic Oncology 2025 June 25 [Link] Ibiayi Dagogo-Jack, Owen Mitchell, Elizabeth Codd, Annie Li, Dawn Mitchell, Samantha E Flynn, Nanna Sivamanoharan, Patrick Reeves, Mark Poznansky, Ivan Valiev, Artem…

HMGB1 as a Key Mediator in Malignant Mesothelioma and a Potential Target for Asbestos-Related Cancer Therapy

August 7, 2025 | Comments Off on HMGB1 as a Key Mediator in Malignant Mesothelioma and a Potential Target for Asbestos-Related Cancer Therapy

Toxics 2025 May 28 [Link] Yi-Fang Zhong, Chan Ding, Chun-Ji Yao, Jia-Chun Wang, Min-Qian Feng, Xiao-Xue Gong, Lin Yu, Hua-Dong Xu, Hai-Ling Xia Abstract Malignant mesothelioma (MM) is a highly…

Loss of MTAP expression is not an accurate surrogate for CDKN2A homozygous deletions in peritoneal mesothelioma

August 6, 2025 | Comments Off on Loss of MTAP expression is not an accurate surrogate for CDKN2A homozygous deletions in peritoneal mesothelioma

Histopathology 2025 June 25 [Link] Andrea Quaranta, Andrea Marzullo, Francesco Fortarezza, Sonia Maniglio, Concetta Caporusso, Floriana Pentimone, Federica Pezzuto, Domenica Cavone, Teresa Lettini, Mario Magistro, Cecilia Salzillo, Luigi Vimercati, Paolo…

Categories